| Clinical Trials
- Brain Tumors |
|
| |
| |
MEDULLOBLASTOMA |
| |
| |
|
For Information: |
|
617-724-1836 |
| |
|
|
| |
| |
|
Protocol #: |
|
MGH 99-271 Medullo |
| |
|
Investigator: |
|
Nancy J. Tarbell, MD |
| |
|
Description: |
|
Proton Therapy for Medulloblastoma and Other CNS Tumors
–
A Prospective Look at Acute and Long-Term Sequelae |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ACNS0331 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Standard Risk Medulloblastoma |
| |
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
| |
|
Protocol #: |
|
COG ACNS0332 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Carboplatin with Radiation Therapy and Isotretinoin for Other than Average Risk Medulloblastoma/PNET |
| |
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
| |
|
Protocol #: |
|
PBTC-016 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Lapatinib for Recurrent or Refractory Medulloblastoma |
| |
|
| |
EPENDYMOMA |
| |
|
|
|
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
PBTC-016 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Lapatinib for Recurrent or Refractory Ependymoma |
| |
| |
BRAIN STEM Tumors
or GLIOMAS |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ACNS0222 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Motexafin-Gadolinium and Radiation Therapy for the Treatment of Pontine Glioma |
| |
| |
|
For Information |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 014 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Zarnestra and XRT in Newly Diagnosed Brainstem Glioma |
| |
| |
|
For Information |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 015 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
O6-Benzylguanine and Temozolomide in Recurrent or Progressive High-Grade Gliomas or Brain Stem Gliomas |
| |
| |
|
For Information |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 016 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Lapatinib for Recurrent or Refractory Glioma |
| |
| |
|
For Information |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 021 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Capecitabine and Radiation Therapy in Newly Diagnosed Brainstem and High Grade Gliomas |
| |
| |
|
For Information |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
PBTC 022 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Bevacizumab and Irinotecan in Recurrent, Progressive or Refractory Malignant Gliomas and Diffuse/Intrinsic Brain Stem Gliomas |
| |
| Back to the Top |
| |
| |
BRAIN TUMORS - RECURRENT
OR PROGRESSIVE |
| |
| |
|
For Information |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 015 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
O6-Benzylguanine and Temozolomide in Recurrent
or Progressive High-Grade Gliomas or Brain Stem Gliomas |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 016 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Lapatinib in Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
PBTC 018 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Lenalidomide Recurrent or Refractory Primary CNS Tumors |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 020 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
AZD2171 in Recurrent or Progressive Central Nervous System (CNS) Tumors |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
PBTC 022 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Bevacizumab and Irinotecan in Recurrent, Progressive or Refractory Malignant Gliomas and Diffuse/Intrinsic Brain Stem Gliomas |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
PBTC 023 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Enzastaurin in Refractory Primary CNS Tumors |
| |
| |
CNS GERMINOMA |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ACNS0232 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Radiation Therapy vs Chemotherapy Followed by Radiotherapy for Newly Diagnosed Primary CNS Germinoma |
| |
| Back to the Top |
|
| Trials
for Pediatric Leukemia/Lymphoma |
|
| |
| |
LEUKEMIA – Precursor
B Cell |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG AALL0331 |
| |
|
Investigator: |
|
Alison M. Friedmann, MD |
| |
|
Description: |
|
Standard-Risk Acute Lymphoblastic Leukemia (ALL) |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
COG AALL0232 |
| |
|
Investigator: |
|
Alison M. Friedmann, MD |
| |
|
Description: |
|
High-Risk Acute Lymphoblastic Leukemia (ALL) |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG AAML0531 |
| |
|
Investigator: |
|
Howard Weinstein , MD |
| |
|
Description: |
|
Newly Diagnosed Acute Myelogenous Leukemia (AML) |
| |
| |
HODGKIN DISEASE |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
HOD99 |
| |
|
Investigator: |
|
Howard J. Weinstein, MD |
| |
|
Description: |
|
Risk-Adapted Therapy in Pediatric Hodgkin Disease (Low Risk and High Risk) |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
|
Protocol #: |
|
HOD05 |
| |
|
Investigator: |
|
Alison M. Friedmann, MD |
| |
|
Description: |
|
Intermediate Risk Hodgkin Disease |
| |
|
|
|
|
| |
NON-HODGKIN LYMPHOMA |
| |
|
|
|
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
COG ANHL01P1 |
| |
|
Investigator: |
|
Howard Weinstein, MD |
| |
|
Description: |
|
Advanced B-Cell Leukemia/Lymphoma |
| |
|
|
|
|
| |
| Back to the Top |
|
| Clinical Trials
- Sarcomas |
|
| |
| |
EWING SARCOMA |
| |
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
Protocol #: |
|
COG AEWS0621 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Recurrent or Refractory Ewing Sarcoma |
| |
|
| |
OSTEOSARCOMA |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG AOST0331 |
| |
|
Investigator: |
|
David H. Ebb, MD |
| |
|
Description: |
|
Newly Diagnosed Osteosarcoma |
| |
| |
RHABDOMYOSARCOMA |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ARTS0331 |
| |
|
Investigator: |
|
Alison M. Friedmann, MD |
| |
|
Description: |
|
Low-Risk Rhabdomyosarcoma |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ARTS0431 |
| |
|
Investigator: |
|
Alison M. Friedmann, MD |
| |
|
Description: |
|
High-Risk Rhabdomyosarcoma |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ARTS0531 |
| |
|
Investigator: |
|
Alison M. Friedmann, MD |
| |
|
Description: |
|
Intermediate-Risk Rhabdomyosarcoma |
| |
| |
|
For Information |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
04-188 |
| |
|
Investigator: |
|
Torunn Yock, MD |
| |
|
Description: |
|
Phase II trial of Proton Radiation for the treatment
of Pediatric Rhabdomyosarcoma |
| |
| Back to the Top |
|
| Clinical
Trials - Other Solid Tumors |
|
| |
| |
GERM CELL TUMORS |
| |
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
| |
|
Protocol #: |
|
COG AGCT0132 |
| |
|
Investigator: |
|
Mary Huang, MD |
| |
|
Description: |
|
Low and Intermediate Risk Extracranial Germ Cell Tumors |
| |
|
| |
RENAL TUMORS |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG AREN0321 |
| |
|
Investigator: |
|
Mary Huang, MD |
| |
|
Description: |
|
High Risk Renal Tumors |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
COG AREN0532 |
| |
|
Investigator: |
|
Mary Huang, MD |
| |
|
Description: |
|
Low and Standard Risk Favorable Wilms Tumor |
| |
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG AREN0533 |
|
| |
|
Investigator: |
|
Mary Huang, MD |
| |
|
Description: |
|
High Risk Favorable Wilms Tumor |
| |
| |
| |
RETINOBLASTOMA |
| |
|
|
|
|
| |
|
For Information: |
|
617-724-0857 |
| |
|
|
|
|
| |
|
Protocol #: |
|
COG ARET0332 |
| |
|
Investigator: |
|
Eric Grabowski, MD |
| |
|
Description: |
|
Unilateral Retinoblastoma |
| |
|
|
|
|
| |
|
For Information: |
|
617-724-0857 |
| |
| |
|
Protocol #: |
|
COG ARET0331 |
| |
|
Investigator: |
|
Eric Grabowski, MD |
| |
|
Description: |
|
Chemotherapy for Group B Intraocular Retinoblastoma |
| |
| Back to the Top |
